Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-10-28 Option Award | 2024-10-30 8:30 pm | N/A 2034-10-27 | Skye Bioscience Inc. | SKYE | Schwab Andrew J. Director | 70,000 | $0 | 70,000 (Direct) | View |
| 2024-10-15 Conversion | 2024-10-15 5:48 pm | N/A N/A | Camp4 Therapeutics Corp | CAMP | Schwab Andrew J. Director 10% Owner | 24,661,577 | $0 | 2,625,145 (Indirect) | View |
Ownership | 2024-10-10 9:05 pm | N/A N/A | Camp4 Therapeutics Corp | CAMP | Schwab Andrew J. Director 10% Owner | 0 | $0 | 2,018,825 (Indirect) | View |
| 2024-07-22 Conversion | 2024-07-24 4:15 pm | N/A N/A | Artiva Biotherapeutics Inc. | ARTV | 5AM Partners VI LLC 5AM Ventures VI L.P. 5AM Opportunities II (GP) LLC 5AM Opportunities II L.P. PARMAR KUSH Schwab Andrew J. 10% Owner | 2,116,568 | $0 | 1,643,741 (Indirect) | View |
| 2024-07-22 Other | 2024-07-24 4:15 pm | N/A N/A | Artiva Biotherapeutics Inc. | ARTV | 5AM Partners VI LLC 5AM Ventures VI L.P. 5AM Opportunities II (GP) LLC 5AM Opportunities II L.P. PARMAR KUSH Schwab Andrew J. 10% Owner | 461,687 | $10.2 | 1,643,741 (Indirect) | View |
Ownership | 2024-07-18 8:06 pm | N/A N/A | Artiva Biotherapeutics Inc. | ARTV | 5AM Partners VI LLC 5AM Ventures VI L.P. PARMAR KUSH Schwab Andrew J. 10% Owner | 0 | $0 | 1,058,284 (Indirect) | View |
| 2024-03-13 Option Award | 2024-03-15 4:15 pm | N/A N/A | Skye Bioscience Inc. | SKYE | Schwab Andrew J. Director 10% Owner | 450,000 | $10 | 10,179,505 (Indirect) | View |
| 2024-02-29 Option Award | 2024-03-04 4:04 pm | N/A 2034-03-01 | Skye Bioscience Inc. | SKYE | Schwab Andrew J. Director | 35,000 | $0 | 35,000 (Direct) | View |
| 2024-01-31 Option Award | 2024-02-02 4:35 pm | N/A N/A | Skye Bioscience Inc. | SKYE | Schwab Andrew J. Director 10% Owner | 5,206,074 | $2.31 | 9,729,505 (Indirect) | View |
| 2023-11-06 Option Award | 2023-11-06 8:29 pm | N/A 2033-08-25 | Skye Bioscience Inc. | SKYE | Schwab Andrew J. Director | 14,110 | $0 | 20,001 (Direct) | View |
| 2023-08-25 Option Award | 2023-08-29 9:36 pm | N/A 2033-08-25 | Skye Bioscience Inc. | SKYE | Schwab Andrew J. Director | 1,472,692 | $0 | 1,472,692 (Direct) | View |
| 2023-08-18 Option Award | 2023-08-22 5:21 pm | 2023-08-18 2033-08-18 | Skye Bioscience Inc. | SKYE | Schwab Andrew J. Director 10% Owner | 704,509,037 | $0 | 443,296,919 (Indirect) | View |
| 2023-08-18 Option Award | 2023-08-22 5:21 pm | N/A N/A | Skye Bioscience Inc. | SKYE | Schwab Andrew J. Director 10% Owner | 852,696,240 | $0.0103 | 443,296,919 (Indirect) | View |
| 2023-02-23 Option Award | 2023-04-06 8:22 pm | N/A 2033-02-23 | Enliven Therapeutics Inc. | ELVN | Schwab Andrew J. Director 10% Owner | 27,567 | $0 | 27,567 (Direct) | View |
| 2023-02-24 Equity Swap | 2023-02-28 4:29 pm | N/A N/A | CinCor Pharma Inc. | CINC | 5AM Partners VI LLC 5AM Ventures VI L.P. 5AM Opportunities I L.P. Schwab Andrew J. PARMAR KUSH 5AM Opportunities II (GP) LLC 5AM Opportunities II L.P. 5AM Opportunities I (GP) LLC 10% Owner | 4,937,646 | $0 | 0 (Indirect) | View |
| 2023-02-23 Option Award | 2023-02-27 9:55 pm | N/A N/A | Enliven Therapeutics Inc. | ELVN | Schwab Andrew J. Director | 5,798,475 | $0 | 960,383 (Indirect) | View |
| 2022-11-30 Equity Swap | 2022-12-02 3:38 pm | N/A N/A | Akouos Inc. | AKUS | 5AM Ventures V L.P. 5AM Partners V LLC 5AM Opportunities I L.P. 5AM Opportunities I (GP) LLC ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner | 4,135,786 | $0 | 0 (Indirect) | View |
| 2022-01-11 Conversion | 2022-01-13 4:45 pm | N/A N/A | CinCor Pharma Inc. | CINC | 5AM Partners VI LLC 5AM Ventures VI L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. Schwab Andrew J. PARMAR KUSH 10% Owner | 17,017,645 | $0 | 496,323 (Indirect) | View |
Ownership | 2022-01-06 9:02 pm | N/A N/A | CinCor Pharma Inc. | CINC | 5AM Partners VI LLC 5AM Ventures VI L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. Schwab Andrew J. PARMAR KUSH 10% Owner | 0 | $0 | 3,867,646 (Indirect) | View |
| 2021-12-03 Option Award | 2021-12-07 5:25 pm | N/A N/A | Pear Therapeutics Inc. | PEAR | Schwab Andrew J. Director 10% Owner | 18,431,771 | $0 | 3,372,769 (Indirect) | View |
| 2021-12-03 Option Award | 2021-12-07 5:25 pm | N/A N/A | Pear Therapeutics Inc. | PEAR | Schwab Andrew J. Director 10% Owner | 200,000 | $10 | 3,372,769 (Indirect) | View |